ClassID:

95319

C07D451/00 - CPC Classification

Classification description:

Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof

Sub-classes:
Recent Application in this class:
#1
20250304572
2025-10-02

HETEROCYCLIC GLP-1R AGONISTS

#2
20240327381
2024-10-03

Compounds and Compositions for Selective Degradation of Engineered Proteins

#3
20240025907
2024-01-25

QUINAZOLINE PAN-KRas INHIBITORS

#4
20230373989
2023-11-23

N-PHENYLAMINOCARBONYL PYRIDINO-, PYRIMIDINO AND BENZO-TROPANES AS MODULATORS OF GPR65

#5
20230285381
2023-09-14

Dizocilpine derivatives as peripheral NMDA receptor antagonists

#6
20230020922
2023-01-19

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

#7
20220280498
2022-09-08

Dizocilpine derivatives as peripheral NMDA receptor antagonists

#8
20210171646
2021-06-10

Method of treating hypercytokinemia by administering the CCR5/CCL5 (RANTES) interaction inhibitor maraviroc

#9
20210032355
2021-02-04

Method of treating COVID-19 by administering the CCR5/CCL5 (RANTES) interaction inhibitor maraviroc

#10
20200362044
2020-11-19

Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

#11
20200113889
2020-04-16

Tricyclic compounds and their use in the treatment of cancer

#12
20190314332
2019-10-17

Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases

#13
20190307738
2019-10-10

Dizocilpine derivatives as peripheral NMDA receptor antagonists

#14
20190112311
2019-04-18

Therapeutic compound for pain and synthesis thereof

#15
20180354960
2018-12-13

Biphenyl compound or salt thereof

#16
20180327406
2018-11-15

Therapeutic compounds for pain and synthesis thereof

#17
20180327405
2018-11-15

Therapeutic compounds for pain and synthesis thereof

#18
20180291024
2018-10-11

Therapeutic compounds for pain and synthesis thereof

#19
20180273529
2018-09-27

Bicyclic compound and use thereof for inhibiting SUV39H2

#20
20180237403
2018-08-23

Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer

#21
20180009807
2018-01-11

Inhibitors of the renal outer medullary potassium channel

#22
20170066770
2017-03-09

Therapeutic compound for pain and synthesis thereof

#23
20170066769
2017-03-09

Therapeutic compounds for pain and synthesis thereof

#24
20170066768
2017-03-09

Therapeutic compounds for pain and synthesis thereof

#25
20170066767
2017-03-09

Therapeutic compounds for pain and synthesis thereof

#26
20170066760
2017-03-09

Therapeutic compounds and synthesis

#27
20160346248
2016-12-01

Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases

#28
20160257657
2016-09-08

SMALL MOLECULE INHIBITORS OF THE NUCLEAR TRANSLOCATION OF ANDROGEN RECEPTOR FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER

#29
20160207922
2016-07-21

Inhibitors of the renal outer medullary potassium channel

#30
20150266884
2015-09-24

Compounds and methods for treatment of hypertension

#31
20150148540
2015-05-28

Methods for the synthesis of tiotropium bromide

#32
20150099729
2015-04-09

Inhibitors of the renal outer medullary potassium channel

#33
20150031897
2015-01-29

Quaternary ammonium anti-cholinergic muscarinic receptor antagonists

#34
20140316138
2014-10-23

PROCESS FOR PREPARING NEW TIOTROPIUM SALTS, NEW TIOTROPIUM SALTS AS SUCH AND PHARMACEUTICAL COMPOSITIONS THEREOF

#35
20140228353
2014-08-14

Methods of treating diabetes

#36
20140213585
2014-07-31

Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

#37
20140088086
2014-03-27

Compounds and methods for treatment of hypertension

#38
20140031349
2014-01-30

Inhibitors of the renal outer medullary potassium channel

#39
20140024643
2014-01-23

Bridged heterocyclic compounds and methods of use

#40
20130190303
2013-07-25

Bridged heterocyclic compounds and methods of use

#41
20130190294
2013-07-25

Compounds and methods for treating diabetes

#42
20130184269
2013-07-18

Bridged heterocyclic compounds and methods of use

#43
20130172379
2013-07-04

Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases

#44
20130165656
2013-06-27

Continuous process for the alkylation of cyclic tertiary amines

#45
20130116435
2013-05-09

NEW PROCESS FOR THE PRODUCTION OF TIOTROPIUM SALTS

#46
20130053367
2013-02-28

Compounds and methods of treating diabetes

#47
20130053366
2013-02-28

Compounds and methods for treatment of hypertension

#48
20130030182
2013-01-31

Methods for the synthesis of tiotropium bromide

#49
20130018041
2013-01-17

Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

#50
20120226043
2012-09-06

Method for the N-demethylation of N-methyl heterocycles

#51
20100331544
2010-12-30

METHOD FOR PRODUCING (1R,5S) ANHYDROECGONINE ESTER SALTS

#52
20100210844
2010-08-19

NEW PROCESS FOR THE PRODUCTION OF TIOTROPIUM SALTS

#53
20100152224
2010-06-17

SCOPINE MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR

#54
20100099667
2010-04-22

Bridged heterocyclic compounds and methods of use

#55
20100081680
2010-04-01

N-sulfonamido polycyclic pyrazolyl compounds

#56
20090258864
2009-10-15

Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

#57
20080009489
2008-01-10

ANDROGEN RECEPTOR MODULATORS AND METHOD OF TREATING DISEASE USING THE SAME

#58
20070027320
2007-02-01

New Process for the Production of Tiotropium Salts

#59
20060287530
2006-12-21

Process For Preparing New Tiotropium Salts, New Tiotropium Salts As Such and Pharmaceutical Compositions Thereof

#60
20060014739
2006-01-19

Androgen receptor modulators and method of treating disease using the same